Skip to main content
×
Home
    • Aa
    • Aa

Homocysteine and stroke

  • K Zaw (a1), M T Hasan (a2), B Bhowmick (a1), P B Khanna (a3) and E A Freeman (a4)
  • DOI: http://dx.doi.org/10.1017/S0959259807002316
  • Published online: 01 February 2007
Abstract

Interest in homocysteine's role in vascular disease was stimulated by the paper of McCully (1969) in which, based on autopsy evidence of extensive arterial thrombosis in two children with elevated plasma homocysteine concentrations and homocystinuria, he proposed that elevated plasma homocysteine (hyperhomocysteinaemia) can cause atherosclerotic vascular disease. A meta-analysis of subsequent prospective observational studies concluded that elevated homocysteine is indeed a modest independent predictor of ischaemic heart disease and stroke risk in healthy populations with a 25% reduction in serum homocysteine concentration, a reduction of approximately 3 micromol per litre (μmol/l) being associated with a 19% lower risk of stroke (odds ratio, 0.81; 95% confidence interval (CI), 0.69 – 0.95). In the nationally representative sample of US adults, elevated homocysteine concentration was independently associated with an increased likelihood of non-fatal stroke in both black and white adults. In this article, the current concepts relating homocysteine to ischaemic stroke are reviewed.

Copyright
Corresponding author
Address for correspondence: Khin Zaw, Torfaen Intermediate Care, County Hospital Coed-Y-Gric, Griffithstown, Pontypool, NP4 5YA, Wales, UK.
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

3WH Giles , JB Croft , KJ Greenland , ES Ford , SJ Kittner . Total homocysteine concentration and the likelihood of nonfatal stroke. Results from the third National Health and Nutrition Examination Survey, 1988–1994. Stroke 1998; 29: 2473–77.

4EL Mayer , DW Jacobsen , K Robison . Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996; 27; 517–27.

5P Verhof , MJ Stampfer , JE Buring Homocysteine metabolism and risk of myocardial infarction: relation with vitamin B6, B12 and folate. Am J Epidemiol 1996; 143: 845–59.

6MM Rees , GM Rodgers . Homocysteinaemia : association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 1993; 71: 337–59.

7JB Ubbink . Assay methods for the measurement of total homocysteine in plasma. Semin Thromb Hemost 2006; 26: 233–41.

9SS Kang , PW Wong , MR Malinow . Hyperhomocysteinaemia and risk factors for occlusive vascular disease. Ann Rev Nutr 1992; 12: 279–98.

11K Robinson , E Mayer , DW Jacobson . Homocysteine and coronary artery disease. Cleve Clin J Med 1994; 61: 438–50.

12L Brattstrom , DE Wilcken , J Onrik , L Brudin . Common methylene tetrahydrofolate reductase gene metabolism leads to hyperhomocysteinaemia, but not to vascular disease: result of a meta-analysis. Circulation 1998; 98: 2520–26.

13B Wilken , F Bamforth Geographical and ethnic variation of the 677 C → T allele of 5, 10 methyltetrahydrofolate reductase MTHFR: finding over 7000 newborns from 16 areas worldwide. J Med Genet 2003; 40: 619–25.

14P Frost , HJ Bloom , R Milos A candidate genetic risk factor for vascular disease : a common mutation in methylene tetrahydrofolate reductase. Nat Genet 1995; 10: 111–13.

15F Bruschi , R Daguati , F Parazzini Age, menopausal status and homocysteine levels in women around menopause. Eur J Obstet Gynaecol Reprod Biol 2005; 120: 195–97.

16A Lindgren , L Brattstrom , B Norving , B Hultberg , A Anderson , BB Johansen . Plasma homocysteine in the acute and convalescent phase after stroke. Stroke 1995; 26: 795800.

17DJ Meiklejohn , MA Vickers , R Dijkhuisen , M Greaves . Plasma homocysteine concentration in the acute and convalescent periods of atherothrombotic stroke. Stroke 2001; 32: 5762.

18VJ Howard , EG Sides , GC Newman Stability of Plasma Homocysteine in Acute Stroke Patients (SHASP) Study Investigators. Changes in plasma homocysteine in the acute phase after stroke. Stroke 2002; 33: 473–78.

19G Alfthan , J Pekkanen , M Jauhiainen Relationship of serum homocysteine and lipoprotein concentrations to atherosclerotic disease in a prospective Finnish population-based study. Atherosclerosis 1994; 106: 919.

20P Verhoef , CH Hennekens , MR Malinow A prospective study of plasma homocysteine and risk of ischaemic stroke. Stroke 1994; 25: 1924–30.

21O Nygard , SE Vollset , H Refsum , I Stensvold Total plasma homocysteine and cardiovascular risk profile : the Hordaland Homocysteine study. JAMA 1995; 274: 1526–33.

22IJ Perry , H Refsum , RW Morris , SB Ebrahim , PM Cleland , AG Sharper . Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395–98.

23JF Toole , MR Malinow , LE Chamblers Lowering homocysteine in patients with ischaemic stroke to prevent recurrent stroke, myocardial infarction and death: the Vitamin Intervention for Stroke Prevention VISP randomised controlled trial. JAMA 2004; 291: 565–75.

24ML Bots , LJ Launer , Lindemans Homocysteine and short-term risk of myocardial infarction and stroke in the elderly : the Rotterdam Study. Arch Intern Med 1999; 159: 3844.

25Homocysteine Studies Collaboration. Homocysteine and risk of ischaemic heart disease and stroke. JAMA 2002; 288: 2015–23.

26AG Bostom , IH Rosenberg , H Silbershatz , PF Jacques Non-fasting plasma total homocysteine levels and stroke incidence in the elderly person: The Framingham Study. Ann Int Med 1999; 131: 352–55.

27JW Eikelboom , GJ Hankey , SS Anand , E Lofthouse , N Staples , RI Baker . Association between high homocysteine and ischaemic stroke due to large- and small-artery disease but not other aetiologic subtypes of ischaemic stroke. Stroke 2000; 31: 1069–75.

28NC-K Tan , N Vanketasubramanian , SM Saw , HTL Tjia . Hyperhomocysteinaemia and risk of ischaemic stroke among young Asian adults. Stroke 2002; 33: 1956–62.

29IM Van Der Meer , MPM de Maat , AE Hak C reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree. The Rotterdam study. Stroke 2002; 33: 2750–55.

30LA Harker , SJ Stichter , CR Scott , R Ross . Homocysteinaemia: vascular injury and arterial thrombosis. N Eng J Med 1974; 291: 537–43.

31LA Harker , R Ross , SJ Stichter , CR Scott . Homocysteine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976; 58: 731–41.

32OD Ratnoff . Activation of Hageman factor by L-homocysteine. Science 1968; 162: 1007–9.

33GM Rodgers , WH Kane . Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 1986; 77: 1909–16.

35SR Lentz , JE Sadler . Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 1991; 88: 1906–14.

36RH Fryer , BD Wilson , DB Eubler , LA Fitzgerald , GM Rodgers . Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 1993; 13: 1327–33.

37M Nishinaga , T Ozawa , K Shimade . Homocysteine, a thrombogenic agent, suppresses anticoagulant heparin sulfate expression in cultured porcine aortic endothelial cells. J Clin Invest 1993; 92: 1381–6.

38JC Tsai , H Wang , MA Perrella Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 1996; 97: 146–53.

39W Hermann , M Hermann , R Obeid . Hyperhomocysteinaemia: a critical review of old and new aspects. Curr Drug Metab 2007; 8: 1731.

40The Heart Outcome Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Eng J Med 2006; 354: 1567–77.

41KH Bonaa , I Njostad , PM Cleland Homocysteine-lowering and cardiovascular events after acute myocardial infarction. N Eng J Med 2006; 354: 1578–88.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Reviews in Clinical Gerontology
  • ISSN: 0959-2598
  • EISSN: 1469-9036
  • URL: /core/journals/reviews-in-clinical-gerontology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×